Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Enanta Pharmaceuticals Net Income 2011-2024 | ENTA

Enanta Pharmaceuticals net income from 2011 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  
Enanta Pharmaceuticals Annual Net Income
(Millions of US $)
2023 $-134
2022 $-122
2021 $-79
2020 $-36
2019 $46
2018 $72
2017 $18
2016 $22
2015 $79
2014 $34
2013 $-7
2012 $1
2011 $2
2010 $0
Enanta Pharmaceuticals Quarterly Net Income
(Millions of US $)
2024-03-31 $-31
2023-12-31 $-33
2023-09-30 $-28
2023-06-30 $-39
2023-03-31 $-38
2022-12-31 $-29
2022-09-30 $-26
2022-06-30 $-32
2022-03-31 $-34
2021-12-31 $-30
2021-09-30 $-25
2021-06-30 $-24
2021-03-31 $-22
2020-12-31 $-8
2020-09-30 $-29
2020-06-30 $-14
2020-03-31 $-6
2019-12-31 $13
2019-09-30 $9
2019-06-30 $7
2019-03-31 $4
2018-12-31 $26
2018-09-30 $27
2018-06-30 $20
2018-03-31 $13
2017-12-31 $12
2017-09-30 $37
2017-06-30 $-8
2017-03-31 $-5
2016-12-31 $-5
2016-09-30 $-2
2016-06-30 $-1
2016-03-31 $-2
2015-12-31 $26
2015-09-30 $6
2015-06-30 $2
2015-03-31 $29
2014-12-31 $42
2014-09-30 $-5
2014-06-30 $50
2014-03-31 $-5
2013-12-31 $-5
2013-09-30 $-4
2013-06-30 $-4
2013-03-31 $-5
2012-12-31 $2
2012-09-30 $-5
2012-06-30 $-5
2012-03-31 $3
2011-09-30
2010-09-30
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.264B $0.079B
Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus, respiratory tract infections, intravenous and oral treatments. Enanta Pharmaceuticals, Inc. is headquartered in Watertown, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.369B 31.46
Chugai Pharmaceutical (CHGCY) Japan $50.073B 22.38
Takeda Pharmaceutical (TAK) Japan $42.251B 8.56
Merck (MKGAF) Germany $23.797B 23.07
Astellas Pharma (ALPMY) Japan $17.753B 28.03
Sandoz Group AG (SDZNY) Switzerland $15.296B 0.00
Neurocrine Biosciences (NBIX) United States $13.627B 37.30
Shionogi (SGIOY) Japan $13.297B 11.56
United Therapeutics (UTHR) United States $12.204B 13.01
Catalent (CTLT) United States $9.735B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.423B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.635B 7.29
Revolution Medicines (RVMD) United States $6.324B 0.00
Summit Therapeutics (SMMT) United States $6.097B 0.00
Orion OYJ (ORINY) Finland $5.637B 23.77
Ionis Pharmaceuticals (IONS) United States $5.484B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.033B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.502B 0.00
Corcept Therapeutics (CORT) United States $3.141B 28.46
Arrowhead Pharmaceuticals (ARWR) United States $2.850B 0.00
PTC Therapeutics (PTCT) United States $2.789B 0.00
Dyne Therapeutics (DYN) United States $2.786B 0.00
Indivior (INDV) United States $2.526B 11.97
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.062B 11.72
Recursion Pharmaceuticals (RXRX) United States $1.968B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.910B 18.59
Fusion Pharmaceuticals (FUSN) Canada $1.830B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.687B 0.00
Evotec AG (EVO) Germany $1.658B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.609B 24.19
Ardelyx (ARDX) United States $1.596B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.533B 0.00
Xencor (XNCR) United States $1.465B 0.00
Pacira BioSciences (PCRX) United States $1.412B 13.42
Soleno Therapeutics (SLNO) United States $1.406B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.333B 0.00
4D Molecular Therapeutics (FDMT) United States $1.239B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.191B 0.00
Collegium Pharmaceutical (COLL) United States $1.084B 6.49
Enliven Therapeutics (ELVN) United States $1.062B 0.00
Cassava Sciences (SAVA) United States $1.057B 0.00
Cronos Group (CRON) Canada $0.989B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.986B 15.37
USANA Health Sciences (USNA) United States $0.907B 14.83
Ocular Therapeutix (OCUL) United States $0.883B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.867B 0.00
ARS Pharmaceuticals (SPRY) United States $0.860B 0.00
Relay Therapeutics (RLAY) United States $0.851B 0.00
ProKidney (PROK) United States $0.798B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.773B 0.00
Lyell Immunopharma (LYEL) United States $0.706B 0.00
Sage Therapeutics (SAGE) United States $0.669B 0.00
Exscientia (EXAI) United Kingdom $0.641B 0.00
Harrow (HROW) United States $0.635B 0.00
Silence Therapeutics (SLN) United Kingdom $0.628B 0.00
Savara (SVRA) United States $0.565B 0.00
Heron Therapeutics (HRTX) United States $0.557B 0.00
Lexeo Therapeutics (LXEO) United States $0.548B 0.00
Altimmune (ALT) United States $0.532B 0.00
Siga Technologies (SIGA) United States $0.532B 6.80
Bioventus (BVS) United States $0.530B 20.27
OmniAb (OABI) United States $0.510B 0.00
Larimar Therapeutics (LRMR) United States $0.510B 0.00
KalVista Pharmaceuticals (KALV) United States $0.492B 0.00
Korro Bio (KRRO) United States $0.476B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.457B 0.00
Verve Therapeutics (VERV) United States $0.436B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.419B 0.00
Esperion Therapeutics (ESPR) United States $0.409B 0.00
Organogenesis (ORGO) United States $0.365B 68.75
Verrica Pharmaceuticals (VRCA) United States $0.361B 0.00
Tourmaline Bio (TRML) United States $0.353B 0.00
Xeris Biopharma Holdings (XERS) United States $0.334B 0.00
Nanobiotix S.A (NBTX) France $0.332B 0.00
Fractyl Health (GUTS) United States $0.323B 0.00
ESSA Pharma (EPIX) Canada $0.299B 0.00
Nature's Sunshine Products (NATR) United States $0.287B 18.24
Black Diamond Therapeutics (BDTX) United States $0.269B 0.00
Aquestive Therapeutics (AQST) United States $0.262B 0.00
Foghorn Therapeutics (FHTX) United States $0.248B 0.00
Avita Medical (RCEL) United States $0.248B 0.00
Century Therapeutics (IPSC) United States $0.246B 0.00
Metagenomi (MGX) United States $0.239B 0.00
Acrivon Therapeutics (ACRV) United States $0.238B 0.00
Akebia Therapeutics (AKBA) United States $0.235B 0.00
Nektar Therapeutics (NKTR) United States $0.234B 0.00
Aldeyra Therapeutics (ALDX) United States $0.229B 0.00
Conduit Pharmaceuticals (CDT) United States $0.224B 0.00
Eliem Therapeutics (ELYM) United States $0.224B 0.00
Pyxis Oncology (PYXS) United States $0.220B 0.00
Prelude Therapeutics (PRLD) United States $0.211B 0.00
Zevra Therapeutics (ZVRA) United States $0.195B 0.00
Elite Pharmaceuticals (ELTP) United States $0.186B 17.40
Adherex Technologies (FENC) United States $0.185B 226.00
Profound Medical (PROF) Canada $0.180B 0.00
Incannex Healthcare (IXHL) Australia $0.180B 0.00
Achieve Life Sciences (ACHV) Canada $0.179B 0.00
Cardiol Therapeutics (CRDL) Canada $0.179B 0.00
Telomir Pharmaceuticals (TELO) United States $0.179B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.172B 0.00
Galectin Therapeutics (GALT) United States $0.169B 0.00
CytoDyn (CYDY) United States $0.157B 0.00
MediWound (MDWD) Israel $0.151B 0.00
Regulus Therapeutics (RGLS) United States $0.150B 0.00
Context Therapeutics (CNTX) United States $0.149B 0.00
VAXART, INC (VXRT) United States $0.144B 0.00
Citius Pharmaceuticals (CTXR) United States $0.126B 0.00
OptiNose (OPTN) United States $0.122B 0.00
Karyopharm Therapeutics (KPTI) United States $0.121B 0.00
FibroGen (FGEN) United States $0.119B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.117B 7.82
ProPhase Labs (PRPH) United States $0.098B 0.00
Assertio Holdings (ASRT) United States $0.095B 4.33
PMV Pharmaceuticals (PMVP) United States $0.094B 0.00
SCYNEXIS (SCYX) United States $0.091B 1.28
Relmada Therapeutics (RLMD) United States $0.091B 0.00
Vivani Medical (VANI) United States $0.090B 0.00
AlloVir (ALVR) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Journey Medical (DERM) United States $0.078B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.078B 0.00
Tempest Therapeutics (TPST) United States $0.074B 0.00
Aclaris Therapeutics (ACRS) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.062B 0.00
Nutriband (NTRB) United States $0.060B 0.00
BioLineRx (BLRX) Israel $0.060B 0.00
Protara Therapeutics (TARA) United States $0.058B 0.00
Mural Oncology (MURA) Ireland $0.057B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
Carisma Therapeutics (CARM) United States $0.055B 0.00
DURECT (DRRX) United States $0.053B 0.00
CASI Pharmaceuticals (CASI) China $0.052B 0.00
Inotiv (NOTV) United States $0.049B 0.00
Gain Therapeutics (GANX) United States $0.046B 0.00
NRx Pharmaceuticals (NRXP) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Rafael Holdings (RFL) United States $0.038B 0.00
Lipocine (LPCN) United States $0.037B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
Surrozen (SRZN) United States $0.036B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.035B 0.00
Unicycive Therapeutics (UNCY) United States $0.033B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
BioVie (BIVI) United States $0.028B 0.00
JanOne (JAN) United States $0.028B 0.00
Viracta Therapeutics (VIRX) United States $0.027B 0.00
Oncternal Therapeutics (ONCT) United States $0.027B 0.00
Aptorum Group (APM) United Kingdom $0.026B 0.00
TherapeuticsMD (TXMD) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
Lyra Therapeutics (LYRA) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.019B 0.73
Minerva Neurosciences (NERV) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Alaunos Therapeutics (TCRT) United States $0.017B 0.00
Nuvilex (PMCB) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
CERo Therapeutics Holdings (CERO) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
SHINECO (SISI) China $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
TransCode Therapeutics (RNAZ) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Universe Pharmaceuticals INC (UPC) China $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.31
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 34.44